Delivery Order SPE2DB20D1100-SPE2DB24FC3T9

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,332.87 firm-fixed-price delivery order is for the supply of 4,565,122,442 Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Carvedilol ER 80 mg capsules. The contract, valued at $1,612.23, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of December 17, 2024. The award was made on December 16, 2024, and there was no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Carvedilol ER 20 mg capsules in 30-count packages. The $27,626.52 firm fixed price contract was awarded on July 22, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen. The contract has a completion date of July 23, 2024 and is not set aside for any special category of business. Amerisourcebergen holds several significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Carvedilol ER 20 mg capsules. The $3,495.74 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the provision of Carvedilol ER 40 mg capsules to the U.S. government. The contract, valued at $16,506.45, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Carvedilol ER 20 mg capsules. The contract has a potential value of $11,931.91 and a completion date of February 23, 2024. This award is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $2,413.40 Firm Fixed Price delivery order is for the supply of Carvedilol ER 10 mg capsules. The contract has a performance period extending through May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The $1,112.68 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Carvedilol ER 20 mg capsules. The contract, valued at $3,682.10, was awarded by the Defense Logistics Agency (DLA) on June 20, 2024 and is a firm-fixed-price delivery order with a completion date of June 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that has received numerous federal contract...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of 4564934344 - Carvedilol ER 20mg Capsules (30s) to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,921.70, is a Firm Fixed Price Delivery Order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a potential value of up to $999,999,999.00 through December 31, 2025. This IDC...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3T9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of Carvedilol ER 20 mg capsules on a firm-fixed price basis. The $1,083.67 contract was awarded on June 21, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract did not have a set-aside designation.

Generated 9/20/24, 9:32 AM